Feed BAYRY
BA

Bayer Aktiengesellschaft BAYRY · OTC

$12.51 +1.46% (+$0.18)

Market cap
43.2B €
Enterprise value
77.3B €
P/E
-
Forward P/E
9.6x
PEG
-
P/S
0.9x
P/FCF
65.1x
EV/EBITDA
8.5x
ROIC
9.1%
Gross margin
59.1%
Net margin
-3.6%
Dividend yield
0.26%
Payout ratio
-
Net debt/EBITDA
3.7x
Beta
0.83
Free float
25.0%

About the company

Bayer Aktiengesellschaft is a German multinational pharmaceutical and chemical company headquartered in Leverkusen, founded in 1863. Bayer is known for its wide range of products in healthcare, agriculture, and materials science. The company specializes in the development and manufacture of pharmaceutical drugs, vaccines, agrochemicals, and highly specialized materials, such as plastics and polymers. Bayer is a leader in research and innovation, particularly in oncology, cardiology, and biological sciences. With a global presence, the company operates in many countries worldwide, focusing on sustainable and innovative solutions for health and agriculture.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Bill Anderson

Employees

88,078

Headquarters

Leverkusen

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.